Calendar Longboard Pharmaceuticals, Inc.

Equities

LBPH

US54300N1037

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
19.25 USD -2.53% Intraday chart for Longboard Pharmaceuticals, Inc. +6.89% +219.24%

Chart calendar Longboard Pharmaceuticals, Inc.

55bae7d09ebdceaa1cc9e3.FY1DeA-Me4uKCHX20XTSJIhakGH1nHMnicIqnjEy_0I.Tf96NGu5EPvgfCGasz29E7EZ5AysykB9wq9GzWZxjiZQ2ws6dd9D-OM-Hg~8b7c8384e3bad35f368f4c46d6d4f5fc

Upcoming events on Longboard Pharmaceuticals, Inc.

2024-05-06 Q1 2024 Earnings Release (Projected)
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)

Past events on Longboard Pharmaceuticals, Inc.

2024-03-12 04:01 pm Q4 2023 Earnings Release
2024-02-14 03:20 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-07 01:00 pm Guggenheim Healthcare Talks Biotechnology Conference
2024-01-02 08:30 am PACIFIC Phase 1b/2a Clinical Trial Results Call
2023-12-04 02:00 pm American Epilepsy Society Meeting
2023-12-04 12:00 pm American Epilepsy Society Meeting - Poster number: 3.270
2023-12-04 12:00 pm American Epilepsy Society Meeting - Poster number: 3.261
2023-12-04 12:00 pm American Epilepsy Society Meeting - Poster number: 3.269
2023-11-30 01:45 pm Evercore ISI HealthCONx Conference - Fireside Chat
2023-11-29 01:30 pm Piper Sandler Healthcare Conference - Fireside Chat
2023-11-07 02:30 pm Guggenheim Securities Inflammation & Immunology Conference - Fireside Chat
2023-11-02 04:01 pm Q3 2023 Earnings Release
2023-10-11 09:30 am Investor & Analyst Day
2023-09-28 09:45 am Cantor Global Healthcare Conference
2023-09-12 08:30 am H.C. Wainwright Global Investment Conference
2023-09-10 American College of Clinical Pharmacology Meeting
2023-09-06 Citi BioPharma Conference
2023-09-05 09:00 am International Epilepsy Congress - 5-HT2C Agonist (#749)
2023-09-05 09:00 am International Epilepsy Congress - A 5-HT2C Superagonist (#754)
2023-09-05 09:00 am International Epilepsy Congress - Epileptic Encephalopathies (#758)

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

2,50

EBITDA
Million USD
Released
Forecast
Spread
0,00


-27,8
-27,3
-2.08%
-44,8
-45,7
1.95%
-56,8
-55,1
-2.98%

-81,9

EBIT
Million USD
Released
Forecast
Spread
0,00


-27,8
-26,4
-5.33%
-44,8
-45,8
2.27%
-56,8
-56,3
-0.76%

-77,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-27,8
-26,0
-7.08%
-43,9
-45,3
2.91%
-54,4
-54,4
-0.02%

-73,9

Net income
Million USD
Released
Forecast
Spread
-14,4


-27,8
-26,0
-7.08%
-43,9
-45,3
3.07%
-54,4
-54,4
-0.02%

-73,9

EPS
USD
Released
Forecast
Spread
-5,22


-1,93
-1,80
-7.22%
-2,56
-2,59
1.01%
-2,39
-2,41
0.67%

-2,12

Announcement Date19/02/2103/03/2202/03/2312/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


2,50


0,00




EBITDA
Million USD
Released
Forecast
Spread



-9,62
-9,50
-1.25%
-11,6
-9,50
-21.74%
-11,9
-10,7
-11.06%
-11,7
-12,0
2.28%
-12,0
-12,8
6.55%
-15,6
-12,3
-27.15%
-13,6
-16,0
15.12%
-15,6
-13,9
-11.87%

-15,7


-16,8


-18,2


-19,5




EBIT
Million USD
Released
Forecast
Spread
-8,79
-7,10
-23.86%
-9,62
-9,30
-3.44%
-11,6
-9,85
-17.43%
-11,9
-11,4
-4.02%
-11,7
-12,7
7.39%
-12,0
-13,2
9.21%
-15,6
-13,3
-17.51%
-13,6
-16,4
17.35%
-15,6
-15,2
-2.66%

-16,4


-17,7


-19,2


-20,6




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,77
-6,95
-26.28%
-9,60
-9,10
-5.46%
-11,4
-9,50
-20.07%
-11,6
-11,0
-5.74%
-11,3
-12,7
10.4%
-11,5
-13,2
12.88%
-15,0
-13,2
-13.23%
-12,9
-16,4
21.13%
-15,0
-15,0
-0.35%

-15,9


-16,4


-18,0


-19,4




Net income
Million USD
Released
Forecast
Spread
-8,77
-6,95
-26.28%
-9,60
-9,10
-5.46%
-11,4
-9,50
-20.07%
-11,6
-11,0
-5.74%
-11,3
-12,7
10.4%
-11,5
-13,2
12.88%
-15,0
-13,2
-13.23%
-12,9
-16,4
21.13%
-15,0
-15,0
-0.35%

-15,9


-16,4


-18,0


-19,4




EPS
USD
Released
Forecast
Spread
-0,52
-0,40
-30%
-0,56
-0,49
-14.29%
-0,67
-0,54
-23.31%
-0,68
-0,57
-19.3%
-0,66
-0,68
2.94%
-0,56
-0,57
1.75%
-0,65
-0,60
-9.06%
-0,55
-0,70
21.43%
-0,62
-0,60
-4.17%

-0,49


-0,48


-0,46


-0,57


-0,57

Announcement Date03/03/2205/05/2204/08/2203/11/2202/03/2309/05/2303/08/2302/11/2312/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LBPH Stock
  4. Calendar Longboard Pharmaceuticals, Inc.